SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875045-22-000003
Filing Date
2022-02-03
Accepted
2022-02-03 07:03:25
Documents
14
Period of Report
2022-02-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K biib-20220203.htm   iXBRL 8-K 31976
2 EX-99.1 exhibit991-q42021pressrele.htm EX-99.1 509813
6 biogenlogostandarda29a.jpg GRAPHIC 756402
  Complete submission text file 0000875045-22-000003.txt   1741563

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biib-20220203.xsd EX-101.SCH 1933
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biib-20220203_lab.xml EX-101.LAB 24275
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biib-20220203_pre.xml EX-101.PRE 12662
8 EXTRACTED XBRL INSTANCE DOCUMENT biib-20220203_htm.xml XML 10549
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 22586523
SIC: 2836 Biological Products, (No Diagnostic Substances)